RPL8B Antibody

What is RPL8 and what are its biological functions?

RPL8 (Ribosomal Protein L8) belongs to the L2P family and functions as a component of the large ribosomal subunit. The ribosome is a large ribonucleoprotein complex responsible for protein synthesis in cells . Beyond its canonical role in translation, RPL8 performs important extraribosomal regulatory functions. Research has demonstrated that RPL8:

• Regulates the reproductive cycle of mosquitoes

• Participates in RNA processing during intervertebral disc degeneration

• Interacts with transcription factors like Pax6 to influence cellular traits

• Has significant roles in oncogenesis and tumor development

RPL8 is also known as large ribosomal subunit protein uL2 or 60S ribosomal protein L8 .

What research applications are appropriate for RPL8 antibodies?

RPL8 antibodies can be effectively utilized in multiple research applications:

The predicted molecular weight of RPL8 is approximately 28 kDa, which should be considered when analyzing Western blot results .

What cell types and tissues have been validated for RPL8 antibody use?

Based on documented research, RPL8 antibodies have been successfully tested in:

• Human cell lines: HepG2, Molt4, A431, and NCIN87 xenografts

• Mouse tissue: Brain tissue samples

• Applications: Successfully applied in WB, IHC-P, and ICC/IF applications with these samples

Some antibodies, such as the rabbit polyclonal ab155136, have been specifically tested and validated with human and mouse samples, showing reliable detection of the predicted 28 kDa band .

How can RPL8 antibodies be used to investigate cancer biology?

RPL8 has been implicated in oncogenesis and tumor development through several mechanisms. Researchers can utilize RPL8 antibodies to:

• Study differential expression: RPL8 has been found dysregulated in osteosarcoma and hepatocellular carcinoma .

• Investigate cellular phenotypes: RPL8 overexpression has been shown to:

  • Inhibit cell proliferation

  • Promote cell apoptosis

  • Potentially affect angiogenesis and inflammatory responses

• Examine gene regulation: RPL8 regulates the expression of cancer-related genes including:

  • Upregulated genes: AVPR2, DLL4, IL23A, FGF1

  • Downregulated genes: ACSF2, C8G, FCGR2A, FOS

• Analyze alternative splicing: RPL8 has been shown to regulate alternative splicing events in key genes including:

  • TBX3 (cassette exon)

  • CASP3 (exon skipping)

  • MBNL3 (cassette exon)

  • SEPT2 (alternative 5' splice sites)

Methodological approach: Combine RPL8 antibody detection with transcriptome analysis to understand its dual role in gene expression and splicing regulation.

What optimization strategies should be employed for Western blot detection of RPL8?

For optimal Western blot results with RPL8 antibodies, consider these technical parameters:

Additional considerations:

• Include appropriate positive controls (HepG2, Molt4, or mouse brain lysates)

• Run size markers to confirm the 28 kDa band position

• Optimize transfer conditions for proteins in this molecular weight range

• Consider gradient gels if detecting multiple proteins of varying sizes simultaneously

What methods can be used to validate the specificity of RPL8 antibodies?

When validating RPL8 antibodies, employ these approaches:

• Genetic validation:

  • RPL8 knockdown or knockout: Compare antibody signal in wild-type versus RPL8-depleted samples

  • Overexpression: Validate with RPL8 overexpression systems as described in research using RPL8-OE HeLa cells

• Analytical validation:

  • Western blot: Confirm the predicted 28 kDa band size

  • Comparison across multiple cell lines with known RPL8 expression

  • Peptide competition assays

• Cross-application validation:

  • Confirm consistent results across applications (WB, IHC-P, ICC/IF)

  • Compare subcellular localization patterns with known ribosomal protein distribution

• Functional correlation:

  • Correlate protein detection with phenotypic changes (e.g., proliferation inhibition and apoptosis promotion when RPL8 is overexpressed)

How should researchers design experiments to investigate RPL8's role in gene expression and splicing?

To investigate RPL8's dual roles in gene expression and splicing regulation:

• Experimental approach:

  • Establish RPL8 overexpression (RPL8-OE) or knockdown systems

  • Use appropriate vector controls (empty vector transfected cells)

  • Monitor cellular phenotypes (proliferation, apoptosis)

  • Perform transcriptome sequencing for comprehensive analysis

• Analysis strategy:

  • Identify differentially expressed genes (DEGs)

  • Detect regulated alternative splicing events (RASEs)

  • Perform pathway enrichment analysis for both DEGs and RASEs

  • Validate findings with RT-qPCR

• Key pathways to investigate:

  • Cell proliferation regulation

  • Apoptosis pathways

  • Angiogenesis

  • Inflammatory responses

• Validation methods:

  • RT-qPCR for DEGs and RASEs

  • Western blot for protein-level changes

  • Functional assays (MTT for proliferation, flow cytometry for apoptosis)

What imaging techniques are most effective for visualizing RPL8 localization using antibodies?

For optimal visualization of RPL8 cellular localization:

• Immunofluorescence optimization:

  • Methanol fixation has been successfully used for RPL8 detection

  • Recommended antibody dilution: 1:200 (for ab155136)

  • Co-staining with nuclear markers (e.g., Hoechst 33342) helps establish subcellular context

• Advanced imaging approaches:

  • Confocal microscopy for high-resolution subcellular localization

  • Super-resolution techniques for detailed examination of ribosomal integration

  • Z-stack imaging to capture the three-dimensional distribution

• Multi-label strategies:

  • Co-stain with markers for cellular compartments (nucleolus, ER, mitochondria)

  • Combine with RNA visualization techniques to study RPL8-RNA interactions

  • Consider proximity ligation assays for detecting RPL8 protein-protein interactions

How can antibodies against RPL8 be used in understanding specialized ribosomes?

Specialized ribosomes with distinct compositions may preferentially translate specific mRNA subsets. RPL8 antibodies can contribute to this research through:

• Compositional analysis:

  • Immunoprecipitate ribosomes using RPL8 antibodies

  • Compare ribosome populations across different tissues and conditions

  • Assess changes in ribosome composition during stress responses or disease states

• Functional studies:

  • Analyze mRNAs associated with RPL8-containing ribosomes

  • Compare translational outputs between different ribosome populations

  • Investigate RPL8's impact on specialized translation during cancer progression

• Structural insights:

  • Use antibodies for selective ribosome purification

  • Study how RPL8 affects ribosome conformation or interaction patterns

  • Examine changes during cancer-related translational reprogramming

What are common issues when working with RPL8 antibodies and how can they be resolved?

Advanced troubleshooting considerations:

• For functional studies, compare results from antibody detection with genetic manipulation approaches

• Consider that RPL8 may have different accessibility when incorporated into ribosomes versus free state

• Account for potential cell type-specific expression patterns or post-translational modifications

How can researchers integrate RPL8 antibody data with transcriptomic findings?

To effectively integrate protein-level data from antibody-based detection with transcriptomic findings:

• Correlation analysis:

  • Compare protein expression (from Western blots) with mRNA levels (from RNA-seq)

  • Look for concordance or discordance between protein and mRNA changes

  • Analyze potential post-transcriptional regulation mechanisms

• Integrative workflow:

  • Identify DEGs and RASEs through RNA-seq analysis

  • Validate protein-level changes using antibody-based methods

  • Correlate changes with functional phenotypes

• Data visualization approaches:

  • Create integrated heatmaps of protein and mRNA changes

  • Use IGV-sashimi plots to visualize alternative splicing events (as shown for TBX3, CASP3, MBNL3, and SEPT2)

  • Develop pathway models incorporating both transcriptomic and proteomic data

• Validation strategy:

  • RT-qPCR to validate transcriptomic findings

  • Western blot to confirm protein-level changes

  • Functional assays to link molecular changes to biological outcomes

How might RPL8 antibodies contribute to understanding cancer diagnostics and therapeutics?

Based on current research, RPL8 antibodies could contribute to cancer research in several ways:

• Diagnostic applications:

  • Tissue-based detection of RPL8 dysregulation in tumors

  • Correlation with tumor stage, grade, and patient outcomes

  • Development of diagnostic panels incorporating RPL8 status

• Mechanistic insights:

  • Understanding RPL8's role in regulating:

    • Cell proliferation pathways

    • Apoptosis resistance mechanisms

    • Angiogenesis and inflammatory responses

    • Alternative splicing of cancer-related genes

• Therapeutic implications:

  • Potential targeting of RPL8-dependent pathways

  • Modulation of alternative splicing controlled by RPL8

  • Development of approaches targeting cancer-specific ribosome components

• Biomarker development:

  • Evaluation of RPL8 expression or modification patterns as prognostic indicators

  • Assessment of RPL8-associated splicing patterns as predictive biomarkers

  • Integration with other ribosomal protein markers

What emerging technologies are enhancing RPL8 antibody-based research?

Advanced technologies that can enhance RPL8 antibody applications include:

• Antibody engineering approaches:

  • Development of RPL8-specific monoclonal antibodies with improved specificity

  • Generation of recombinant antibody fragments for specialized applications

  • Design approaches that combine deep learning and linear programming for antibody optimization

• Advanced detection methods:

  • Single-cell Western blotting for heterogeneity analysis

  • Spatially resolved proteomic approaches

  • Mass spectrometry-based antibody validation

• Integrated multi-omics:

  • Combined antibody-based proteomics with transcriptomics

  • Integration with ribosome profiling data

  • Correlation with clinical outcomes and phenotypic data

• Computational advances:

  • Machine learning for image analysis of RPL8 immunostaining

  • Structural modeling of RPL8 incorporation into specialized ribosomes

  • Predictive approaches for identifying RPL8 interactors

Research using combined approaches has been particularly effective, as demonstrated by studies integrating RPL8 overexpression with transcriptome analysis to identify differentially expressed genes and regulated alternative splicing events .